Evidence-Based Medicine Guidelines
Dopaminergic agonists for hepatic encephalopathy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dopaminergic Agonists for Hepatic Encephalopathy." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456950/all/Dopaminergic_agonists_for_hepatic_encephalopathy.
Dopaminergic agonists for hepatic encephalopathy. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456950/all/Dopaminergic_agonists_for_hepatic_encephalopathy. Accessed December 5, 2023.
Dopaminergic agonists for hepatic encephalopathy. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456950/all/Dopaminergic_agonists_for_hepatic_encephalopathy
Dopaminergic Agonists for Hepatic Encephalopathy [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456950/all/Dopaminergic_agonists_for_hepatic_encephalopathy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dopaminergic agonists for hepatic encephalopathy
ID - 456950
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456950/all/Dopaminergic_agonists_for_hepatic_encephalopathy
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
